* Varta Raised to Buy at DZ Bank
>>> Down
* Future PLC Cut to Add at Peel Hunt; PT 4,400 pence
>>> Initiation
* Wise Rated New Neutral at Citi; PT 1,030 pence
>>> Call
* ING Most Preferred Benelux Bank, ABN Amro Raised: Morgan Stanley
Macro :
Keep an eye on :
- AMBU DC : Ambu 3Q Revenue DKK973M
- NKT DC : NKT 2Q Adjusted Revenue EU344M
Closing Stock Market SummaryThe S&P 500 (+0.3%) and Dow Jones Industrial Average (+0.3%) eked out intraday and closing record highs on Monday after being down as much as 0.7-0.8% in the morning. This was the fifth straight session they set record highs. The Nasdaq Composite (-0.2%) closed slightly lower while the Russell 2000 fell 0.9%.
Over the weekend and prior to the open, China reported softer-than-expected retail sales, fixed asset investment, and industrial production data for July; the Empire State Manufacturing Survey for August came in weaker than expected; the Taliban seized control of Afghanistan; and CNBC reported the Fed could start tapering as soon as October, depending on the next employment report.
Interestingly, the futures market was down very modestly, suggesting it wasn't overly concerned about the negative-sounding news flow or the continued spread of the Delta variant in the U.S.
The overreaction came in the first 90 minutes of action: the S&P 500 information technology sector declined as much as 1.1%, oil prices ($67.34, -0.47, -0.7%) declined as much as 4%, and the 10-yr yield declined as many as six basis points to 1.24%.
The rest of the session saw a steady, and mechanical, advance in the large-cap indices as investors bought the dip on no specific news. The technology sector closed higher by 0.4% amid record-setting gains in Apple (AAPL 151.12, +2.02, +1.4%) and Microsoft (MSFT 294.60, +1.75, +0.6%).
The health care (+1.1%), utilities (+0.7%), and consumer staples (+0.6%) sectors outperformed the tech sector and the benchmark index. Conversely, the energy (-1.8%), materials (-0.5%), consumer discretionary (-0.4%), and financials (-0.2%) sectors closed lower.
Energy stocks struggled, even as oil prices pared losses after OPEC+ rejected calls from the U.S. to speed up production, according to Reuters.
Tesla (TSLA 686.17, -31.00, -4.3%) was an individual laggard, falling 4% after confirming that the National Highway Traffic Safety Administration (NHTSA) is investigating incidents in which TSLA vehicles crashed into first responder scenes.
The 10-yr yield settled lower by four basis points to 1.26%, which reflected lingering growth concerns. The 2-yr yield decreased two basis points to 0.20%. The U.S. Dollar Index increased 0.1% to 92.62.
Reviewing Monday's economic data, the Empire State Manufacturing for August decelerated to 18.3 (consensus 26.0) from 43.0 in July. Looking ahead, investors will receive Retail Sales for July, Industrial Production and Capacity Utilization for July, Business Inventories for June, and the NAHB Housing Market Index for August on Tuesday.
- S&P 500 +19.3% YTD
- Dow Jones Industrial Average +16.4% YTD
- Nasdaq Composite +14.8% YTD
- Russell 2000 +11.6% YTD
After Hours Summary: Pres Biden makes remarks on Afghanistan; DNMR +14.9%, TME +2.5% higher on earnings; SMFR -16.4%, FUV -12.6%, ZEV -12.2%, GAN -8.1% lower on earningsAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: DNMR +14.9%, HIPO +6.6%, POWW +5.1%, TME +2.5%, TLS +0.8%
Companies trading higher in after hours in reaction to news: FBRX +14.7% (to announce top-line data from Phase 2 trial of FB-401 on Sept 7), ANDE +5.7% (sells railcar leasing business for $550 mln), USDP +1.6% (expands downstream connectivity at Stroud terminal), SMG +1% (acquires Rhizoflora assets; subsidiary announces investment in Dewey Scientific), CAAP +0.2% (reports passenger traffic for July), OEC +0.1% (announces price increase for Carbon Black in North America)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: SMFR -16.4%, FUV -12.6%, ZEV -12.2%, GAN -8.1%, RBLX -4.5%, SAVE -2.1% (guides Q3 revs below consensus, cites significant irregular operations), MVST -1.9%, AG -0.4%
Companies trading lower in after hours in reaction to news: HPK -12.3% (stock offering), OPEN -4% (convertible notes offering), UPST -3.3% (convertible notes offering), CLVS -0.6% (renews $125 mln "at-the-market" equity offering program), GATO -0.2% (COO steps down), GMED -0.1% (receives FDA 510(k) clearance for Excelsius 3D), ATI -0.1% (sells Flowform Products business for $55 mln), NPTN -0.1% (files for $150 mln mixed securities shelf offering)
Gapping down
In reaction to earnings/guidance:
- SSL -4%, PSFE -3.1%, DOYU -2%, VET -1.3%
Other news:
- JELD -6% (launches secondary offering and repurchase of common stock)
- ARDX -4.9% (files for $150 mln common stock offering)
- GMBL -3.4% (files for 6 mln share common stock offering by selling shareholders)
- PSFE -3.3% (signed a definitive agreement to acquire SafetyPay for $441 million in an all-cash transaction)
- PING -3.1% (commences underwritten public offering of 6,000,000 shares of common stock by investment funds affiliated with Vista Equity Partners)
- BTX -2.4% (files for 6,281,454 share common stock offering by selling shareholders)
- PSTX -2.2% (files for $300 mln mixed securities shelf offering)
- BHP -1.9% (confirms initiated a strategic review of Petroleum business)
- SMTS -1.6% (reports update of 10,000 tonnes per day positive preliminary economic assessment results to now include iron ore production at its Bolivar Mine in Mexico)
Analyst comments:
- ADP -0.8% (downgraded to Neutral from Outperform at Credit Suisse)
- CMG -0.8% (downgraded to Outperform from Strong Buy at Raymond James)
- INVH -0.7% (downgraded to Hold from Buy at Berenberg)
Gapping up
In reaction to earnings/guidance:
- HHR +3.4%, ZH +2.2%, OTLY +1.1%
Other news:
- TVTX +21.2% (topline interim results from the ongoing pivotal Phase 3 PROTECT Study of sparsentan)
- ADMA +18.1% (received FDA approval for its ADMA BioCenters plasma collection facility located in Maryville, Tennessee)
- SONO +9.6% (wins patent infringement case against Google)
- CVAC +9.2% (reports CV2CoV demonstrates improved immune response and protection in preclinical study)
- DMS +5.5% (initiated a process to evaluate potential strategic alternatives to maximize shareholder value)
- ALXO +5% (files mixed securities shelf offering)
- FIGS +2.7% (Soros Fund (George Soros) discloses updated portfolio positions in 13F filing)
- VXX +2.7% (trading higher with early weakness in futures)
- NSH +1.8% (receives shareholder approval for combination with Spire Global; closing expected to occur on August 16)
Analyst comments:
- STX +0.8% (upgraded to Buy from Neutral at UBS)
- CureVac N.V. and GSK announced the publication of preclinical data investigating immune responses as well as the protective efficacy of CureVac's first-generation vaccine candidate, CVnCoV, and second-generation vaccine candidate, CV2CoV, against SARS-CoV-2 challenge in non-human primates. The study assessed cynomolgus macaques vaccinated with 12µg of either the first or second-generation vaccine candidate. Better activation of innate and adaptive immune responses was achieved with CV2CoV, resulting in faster response onset, higher titers of antibodies and stronger memory B and T cell activation as compared to the first-generation candidate, CVnCoV. Higher antibody neutralizing capacity was observed with CV2CoV across all selected variants, including the Beta, Delta and Lambda variants. During challenge with the original SARS-CoV-2 virus, animals vaccinated with CV2CoV were found to be better protected based on highly effective clearance of the virus in the lungs and nasal passages. The full manuscript of the preclinical data is available on the preprint server bioRxiv.
- Within the study, CVnCoV and CV2CoV were tested in cynomolgus macaques immunized with a 12µg dose of the respective candidate on day 0 and day 28. Induction of innate immunity was investigated via specific cytokine markers. Adaptive immune responses were assessed based on receptor binding domain specific antibodies and neutralizing antibodies as well as memory B and T cells. Impact of Variants of Concern and Variants of Interest on neutralizing antibody titers was tested against the Alpha, Beta, Delta, Kappa and the Lambda variant. Clearance of the virus in the lungs and nasal passages of the animals was tested following challenge infection with the original virus.